DUBLIN, Calif. and JENA, Germany, March 5, 2012 /PRNewswire/ -- Medical technology provider Carl Zeiss Meditec has been awarded the NorthFace ScoreBoard (NFSB) Award(SM) from the Omega Management Group Corp. in recognition of achieving excellence in customer service and support in 2011. This is the ninth straight year that the company has been honored with this award.
Since 2000, the award has been presented annually to companies who, as rated solely by their own customers, achieved excellence in customer satisfaction and provided exemplary customer service during the prior calendar year.
“We want to be the partner of choice to all our customers and support them to be successful,” says Dr. Ludwin Monz, President and CEO of Carl Zeiss Meditec AG. “We are honored to receive this award and thank our customers for recognizing our dedication to providing superior customer service and support. This award motivates us to continually enhance our customer focus.”
Omega’s proprietary NFSB award methodology measures customer satisfaction and loyalty a minimum of four times during the year. For 2011, Carl Zeiss Meditec received scores ranging from 4.5 4.7 on a five-point scale, with customers rating their satisfaction of the company’s sales managers, call center and technical support, in-house repair, field service, product installation and clinical application training.
“As a nine-time recipient of the NorthFace ScoreBoard Award, Carl Zeiss Meditec demonstrates not only exemplary customer service, but that they also center their existence on a deep commitment to exceeding customer expectations,” said John Alexander Maraganis, president and chief executive officer of Omega.
Brief profile
Carl Zeiss Meditec AG (ISIN: DE 0005313704), which is listed on TecDAX of the German stock exchange, is one of the world’s leading medical technology suppliers. The company supplies innovative technologies and application-oriented solutions designed to help doctors improve the quality of life of their patients. It provides complete packages of solutions for the diagnosis and treatment of eye diseases - including implants and consumable materials. The company creates innovative visualisation solutions in the field of microsurgery. Carl Zeiss Meditec’s medical technology portfolio is rounded off by promising future technologies such as intraoperative radiation therapy. In the 2010/2011 (30 September) financial year the approx. 2,400 employees generated revenue of euro 759 million.
The head office of Carl Zeiss Meditec is in Jena, Germany. The company has subsidiaries in Germany and abroad; more than 50 percent of its employees are based in the USA, Japan, Spain and France. Thirty-five percent of Carl Zeiss Meditec shares are in free float. The remaining 65 percent are held by Carl Zeiss AG, one of the world’s leading groups in the optical and opto-electronics industry. Carl Zeiss offers innovative solutions for the future-oriented markets of Industrial Solutions, Research Solutions, Medical Technology and Consumer Optics. In fiscal year 2010/11 the company’s approx. 24,000 employees generated revenue of about 4.237 billion euros. Carl Zeiss AG is wholly owned by the Carl Zeiss Stiftung (Carl Zeiss Foundation). Founded in 1846 in Jena, the company is headquartered in Oberkochen, Germany.
For further information see: www.meditec.zeiss.com
SOURCE Carl Zeiss Meditec, Inc.
